• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester (CAS No. 111054-54-7): A Comprehensive Overview in Modern Chemical Biology

The compound 1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester, identified by the CAS number 111054-54-7, represents a significant molecule in the realm of chemical biology and pharmaceutical research. This compound, belonging to the pyridine derivative family, has garnered attention due to its structural versatility and potential biological activities. The ethyl ester moiety enhances its solubility and reactivity, making it a valuable intermediate in synthetic chemistry and drug development.

Pyridine derivatives are well-documented for their broad spectrum of biological interactions, including roles as pharmacophores in various therapeutic agents. The structural framework of 1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester allows for modifications that can fine-tune its pharmacological properties. Recent studies have highlighted its utility in the synthesis of novel compounds with potential applications in treating neurological disorders and infectious diseases.

In the context of modern drug discovery, the compound's ability to serve as a scaffold for further derivatization has been exploited by researchers aiming to develop more effective therapeutic agents. The dihydro substitution at the 3 and 4 positions introduces conformational flexibility, which is often a desirable feature in drug candidates. This flexibility can influence binding affinity and metabolic stability, critical factors in drug design.

One of the most compelling aspects of 1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester is its role in the development of small-molecule inhibitors targeting specific enzymatic pathways. For instance, studies have demonstrated its efficacy in modulating enzymes involved in inflammation and oxidative stress. These pathways are implicated in a variety of chronic diseases, making this compound a promising candidate for further investigation.

The synthesis of 1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester involves multi-step organic reactions that highlight the compound's synthetic accessibility. Advanced synthetic methodologies have enabled researchers to produce this compound with high purity and yield, facilitating its use in downstream applications. Techniques such as catalytic hydrogenation and esterification play crucial roles in constructing its core structure.

Recent advancements in computational chemistry have further enhanced the understanding of 1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester's interactions with biological targets. Molecular docking studies have identified potential binding sites on proteins relevant to disease pathways. These insights have guided the design of analogs with improved pharmacokinetic profiles and reduced side effects.

The compound's derivatives have shown promise in preclinical trials as potential treatments for conditions such as cancer and neurodegenerative diseases. By leveraging its structural features, researchers have been able to develop molecules that exhibit targeted action while minimizing off-target effects. This underscores the importance of 1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester as a building block in medicinal chemistry.

The ethical considerations surrounding drug development are also pertinent when discussing compounds like 1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester. Ensuring that research is conducted responsibly and with consideration for environmental impact is paramount. Sustainable synthetic routes and green chemistry principles are being increasingly adopted to minimize waste and reduce energy consumption.

In conclusion,1(2H)-Pyridinecarboxylic acid, 3,4-dihydro-, ethyl ester (CAS No. 111054-54-7) represents a cornerstone in chemical biology and pharmaceutical innovation. Its structural attributes and potential biological activities make it a compelling subject for further research. As our understanding of molecular interactions continues to evolve,1(2H)-Pyridinecarboxylic acid, ethyl ester, will undoubtedly play a pivotal role in shaping the future of drug discovery and development.

• 68471-56-7(1H-Pyrrole-1-carboxylicacid,2,3-dihydro-,ethylester(9CI))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)